Elevated homocysteine concentrations decrease the antihypertensive effect of angiotensin-converting enzyme inhibitors in hypertensive patients

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 1, 2017, Pages 166-172

  Qin, Xianhui ^a   Li, Youbao ^a   Sun, Ningling ^b   Wang, Hong ^c   Zhang, Yan ^d   Wang, Jiguang ^e   Li, Jianping ^d   Xu, Xin ^a   Liang, Min ^a   Nie, Jing ^a   Wang, Binyan ^a   Cheng, Xiaoshu ^f   Li, Nanfang ^g   Sun, Yingxian ^h   Zhao, Lianyou ⁱ   Wang, Xiaobin ^j   Hou, Fan Fan ^a   Huo, Yong ^d  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f NANCHANG UNIVERSITY   (China)

^g Xinjiang Uygur Autonomous Region People's Hospital   (China)

^h CHINA MEDICAL UNIVERSITY   (China)

ⁱ FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^j JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

antihypertensive responses; enalapril based antihypertensive treatment; folic acid therapy; homocysteine concentrations; hypertension

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CREATININE; CYANOCOBALAMIN; ENALAPRIL; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; BLOOD PRESSURE; CHINA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR; TREATMENT OUTCOME; UPREGULATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIOMARKERS; BLOOD PRESSURE; CHINA; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84995494433     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.308515     Document Type: Article

References (27)

1. Wald DS, Law M, Morris JK, Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002 325 1202
2. Sen U, Mishra PK, Tyagi N, Tyagi SC, Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys 2010 57 49 58. doi: 10.1007/s12013-010-9079-y
3. Williams C, Kingwell BA, Burke K, McPherson J, Dart AM, Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr 2005 82 26 31
4. van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD, Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001 21 2072 2079
5. Tan H, Jiang X, Yang F, Li Z, Liao D, Trial J, Magera MJ, Durante W, Yang X, Wang H, Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res 2006 69 253 262. doi: 10.1016/j.cardiores.2005.08.016
6. Jamaluddin MD, Chen I, Yang F, Jiang X, Jan M, Liu X, Schafer AI, Durante W, Yang X, Wang H, Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 2007 110 3648 3655. doi: 10.1182/blood-2007-06-096701
7. Cheng Z, Jiang X, Kruger WD, Praticò D, Gupta S, Mallilankaraman K, Madesh M, Schafer AI, Durante W, Yang X, Wang H, Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice. Blood 2011 118 1998 2006. doi: 10.1182/blood-2011-01-333310
8. Wang H, Jiang X, Yang F, Gaubatz JW, Ma L, Magera MJ, Yang X, Berger PB, Durante W, Pownall HJ, Schafer AI, Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood 2003 101 3901 3907. doi: 10.1182/blood-2002-08-2606
9. Zhang D, Jiang X, Fang P, Yan Y, Song J, Gupta S, Schafer AI, Durante W, Kruger WD, Yang X, Wang H, Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 2009 120 1893 1902. doi: 10.1161/CIRCULATIONAHA.109.866889
10. Zhang D, Fang P, Jiang X, Nelson J, Moore JK, Kruger WD, Berretta RM, Houser SR, Yang X, Wang H, Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res 2012 111 37 49. doi: 10.1161/CIRCRESAHA.112.269472
11. Neves MF, Endemann D, Amiri F, Virdis A, Pu Q, Rozen R, Schiffrin EL, Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II. J Hypertens 2004 22 959 966
12. Sen U, Herrmann M, Herrmann W, Tyagi SC, Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling. Clin Chem Lab Med 2007 45 1771 1776. doi: 10.1515/CCLM.2007.354
13. Huang A, Pinto JT, Froogh G, Kandhi S, Qin J, Wolin MS, Hintze TH, Sun D, Role of homocysteinylation of ACE in endothelial dysfunction of arteries. Am J Physiol Heart Circ Physiol 2015 308 H92 H100. doi: 10.1152/ajpheart.00577.2014
14. Yen CH, Ma YH, Yu HP, Lau YT, Reduction of superior mesenteric hemodynamic responsiveness to [Sar1, Thr8]-angiotensin II and bradykinin, but not sodium nitroprusside, in the presence of homocysteine infusion. Chin J Physiol 2010 53 45 51
15. Huo Y, Li J, Qin X, CSPPT Investigators Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 2015 313 1325 1335. doi: 10.1001/jama.2015.2274
16. Jiang X, Yang F, Tan H, Liao D, Bryan RM Jr, Randhawa JK, Rumbaut RE, Durante W, Schafer AI, Yang X, Wang H, Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 2005 25 2515 2521. doi: 10.1161/01.ATV.0000189559.87328.e4
17. Cheng Z, Jiang X, Pansuria M, Fang P, Mai J, Mallilankaraman K, Gandhirajan RK, Eguchi S, Scalia R, Madesh M, Yang X, Wang H, Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation. Diabetes 2015 64 947 959. doi: 10.2337/db14-0784
18. Laggner H, Hermann M, Esterbauer H, Muellner MK, Exner M, Gmeiner BM, Kapiotis S, The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens 2007 25 2100 2104. doi: 10.1097/HJH.0b013e32829b8fd0
19. Xun P, Liu K, Loria CM, Bujnowski D, Shikany JM, Schreiner PJ, Sidney S, He K, Folate intake and incidence of hypertension among American young adults: a 20-y follow-up study. Am J Clin Nutr 2012 95 1023 1030. doi: 10.3945/ajcn.111.027250
20. Forman JP, Rimm EB, Stampfer MJ, Curhan GC, Folate intake and the risk of incident hypertension among US women. JAMA 2005 293 320 329. doi: 10.1001/jama.293.3.320
21. Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB, Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2016 5 e003768. doi: 10.1161/JAHA.116.003768
22. El-Khairy L, Vollset SE, Refsum H, Ueland PM, Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study. Clin Chem 2003 49 113 120
23. Quinlivan EP, Gregory JF 3rd, Homocysteine, B vitamins, and cardiovascular disease. N Engl J Med 2006 355 206; author reply 209 206; author reply 211
24. Kassab S, Garadah T, Abu-Hijleh M, Golbahar J, Senok S, Wazir J, Gumaa K, The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats. J Renin Angiotensin Aldosterone Syst 2006 7 206 211. doi: 10.3317/jraas.2006.039
25. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 360 1903 1913
26. Wang J, Zhang L, Wang F, Liu L, Wang H, China National Survey of Chronic Kidney Disease Working Group Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens 2014 27 1355 1361. doi: 10.1093/ajh/hpu053
27. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J, Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001 161 695 700